Dechra has announced that DuOtic, its new antibiotic-free, long-acting ear gel for the management of otitis externa associated with Malassezia pachydermatis in dogs, will launch in the UK in March.

DuOtic contains terbinafine, an antifungal, and betamethasone acetate, a corticosteroid.

One tube is administered per affected ear, with a second dose given after seven days.

The maximum clinical response may be seen up to 21 days after the second dose

The product was unveiled earlier this year at an event attended by around 80 vets and nurses, where speakers discussed the importance of a holistic approach to otitis externa and the need for judicious antibiotic use.

Speaking at the event, Tim Nuttall said that antibiotic use “has consequences in terms of antimicrobial resistance and should only be used when justified”.

Speakers highlighted that effective management of otitis externa depends on identifying and addressing primary, predisposing, secondary and perpetuating factors, and on implementing a targeted two-phase treatment approach, comprising induction followed by long-term maintenance.

Routine dermatological assessment, including whole-skin examination, otoscopy and cytology, was emphasised as essential to identifying underlying causes and guiding treatment selection.

The role of the wider veterinary team, including trained veterinary nurses, and clear communication with dog owners were also recognised as key to improving outcomes in yeast-only otitis externa.

https://www.dechra.co.uk/products/dog/prescription/duotic

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.